Envisagenics reposted this
Director, Life Sciences at New York Academy of Sciences | Science Communicator | Connector | Conference Convener | Public Health
The science and business of AI for drug discovery and diagnostics are advancing rapidly, utilizing cutting-edge machine learning algorithms and vast datasets to expedite the identification of new drug candidates and streamline diagnostic processes. Last night, Cure. and The New York Academy of Sciences hosted an exceptional panel discussion on this topic. Prof. Nicholas Dirks from The New York Academy of Sciences set the stage for an in-depth dialogue featuring George Church (Harvard University / Massachusetts Institute of Technology), Thomas Fuchs (Icahn School of Medicine at Mount Sinai / Hasso Plattner Institute), Grant W Mitchell, MD, MBA (Every Cure), and Maria Luisa Pineda, PhD. (Envisagenics), with Seema Kumar, CEO of Cure. moderating the discussion. While challenges were identified —such as data quality/integration, regulatory hurdles, scalability, and funding— it was also expressed that AI is driving significant breakthroughs, reducing development costs, and enhancing the precision of diagnostics, ultimately revolutionizing the healthcare landscape. Thanks to all who helped make this special event happen including Seema Kumar, Caroline D., Susanna Ling, Lauren Ruotolo, Jamila Watkins, and Robin Beth Stephenson. #AI #ArtificialIntelligence #AIDrivenDrugDiscovery
